Introduction Ascertain the percentage of patients in whom judicious use of Computed Tomography Coronary Angiogram (CTCA) and Fractional Flow Reserve (FFRct) prevented unnecessary invasive angiograms.

Medtronic (NYSE:MDT) announced the launch of the EMBRACE trial of its Symplicity Spyral renal denervation (RDN) system.

© 2026 Forbes Media LLC. All Rights Reserved.

© 2026 Forbes Media LLC. All Rights Reserved.

Medtronic (MDT) has cut its full-year earnings outlook, citing the recent IPO of its diabetes business, MiniMed Group (MMED), and the earlier-than-expected FDA approval and commercial launch of ...

Fire chiefs in two departments northwest of Denver, Westminster and Arvada, say gaps in emergency dispatch technology between ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

MDT is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of MDT shares has increased $0.12 since the market last closed. This is a 0.14% ...

Tilt, a family-owned and operated amusement center company based in Texas, has announced plans to open a new location inside ...

Russia and Ukraine exchanged prisoners Saturday but also fired waves of drones at each other overnight, just hours before a ...

Medtronic plc is a stable medical device company currently trading below analyst price targets and undervalued, presenting a potential short-term value opportunity. GLP-1 drugs may not materially ...

Family members of a Northern Colorado couple killed in a 2024 crash near Wiggins say the justice system failed them after the driver was sentenced to limited jail time and could avoid a felony ...